MOH — authorised 20 February 1945
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
🇮🇱 Dextrotubocurarine Chloride in Israel
MOH authorised Dextrotubocurarine Chloride on 20 February 1945
Marketing authorisation
Dextrotubocurarine Chloride in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Israel
Frequently asked questions
Is Dextrotubocurarine Chloride approved in Israel?
Yes. MOH authorised it on 20 February 1945.
Who is the marketing authorisation holder for Dextrotubocurarine Chloride in Israel?
BRISTOL MYERS SQUIBB holds the Israeli marketing authorisation.